Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Schering Aktiengesellschaft
Michael Mccaman
Erno Pungor
Carol Souders
Mei P. Tan
Bayer Schering Pharma Aktiengesellschaft
Bayer Pharma Aktiengesellschaft
Bayer Intellectual Property Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/597,059external-prioritypatent/US5731186A/en
Application filed by Schering Aktiengesellschaft, Michael Mccaman, Erno Pungor, Carol Souders, Mei P. Tan, Bayer Schering Pharma Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property GmbhfiledCriticalSchering Aktiengesellschaft
Publication of CA2245554A1publicationCriticalpatent/CA2245554A1/en
Application grantedgrantedCritical
Publication of CA2245554CpublicationCriticalpatent/CA2245554C/en
Treatment Of Liquids With Adsorbents In General
(AREA)
Abstract
rDSPA .alpha. 1 is produced in commercial quantities and a purity adequate for clinical standards. The production methods utilize a series of chromatographic steps: cation exchange chromatography, followed by hydrophobic interaction chromatography, and ending with affinity chromatography.
CA002245554A1996-02-051997-01-31Method for the production of rdspa .alpha.1
Expired - LifetimeCA2245554C
(en)